Takeda Pharmaceutical's strong earnings, dividends, and strategic moves make it an appealing investment despite US policy ...

Q3 2025 Earnings Call Transcript January 30, 2025 Christopher O’Reilly: [Foreign Language] Let me start, I’d like to remind ...

Koichi Mamegano, an analyst from Bank of America Securities, maintained the Buy rating on Takeda Pharmaceutical Co (TKPHF – Research Report).

Miki Sogi, an analyst from Bernstein, maintained the Hold rating on Takeda Pharmaceutical Co (TKPHF – Research Report). The associated price ...

A Lim Kim made enough birdies in an up-and-down second round to maintain a cushion between herself and top-ranked Nelly Korda at the Hilton Grand Vacations Tournament of Champions, the LGPA Tour ...

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...

India], January 31: Zydus Takeda Healthcare Private Limited (ZTHPL), a joint venture company set up by Zydus Lifesciences ...

Takeda Pharmaceuticals has named Julie Kim as the first woman to lead the 244-year-old Japanese drugmaker, a rarity in senior ...

ORLANDO, Fla. — Top-ranked Nelly Korda had quite the close for herself, and former Red Sox closer Derek Lowe provided a big ...

Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.

South Korea's Kim A-lim heads into the weekend at the LPGA's season-opening Tournament of Champions in Orlando with a three ...